Pharmaceuticals(49)

  • Improved Treatment for Glaucoma (No. T4-1433)

    Glaucoma is one of the leading causes of irreversible blindness worldwide, affecting over 60 million people. It is usually caused due to raised intraocular pressure (IOP). ... Read more
    Emeritus Steven J.D. Karlish

    Steven J.D. Karlish

    Faculty of Biochemistry

    6232
  • On-Chip Synthetic Biology Platform for Diagnostics and Therapeutics (No. T4-1369)

    Cell-free synthetic platforms that enable complex biological activities such as synthesis and self-assembly of biomolecules, can be employed for various applications, including drug discovery and diagnostics. ... Read more
    Full Professor Roy Bar-Ziv

    Roy Bar-Ziv

    Faculty of Chemistry

    5455
  • Cholesterol Antibodies (No. T4-1267)

    Description: Monoclonal antibodies specific for cholesterol/ceramide-rich domains (clones 405F, 14F, 499F) and cholesterol micro-domains (clones 36A1, 5881) in cell membranes. Originally raised against an artificial monolayer of lipid mixtures in, and were shown to specifically label the above do ... Read more
    Emeritus Lia Addadi

    Lia Addadi

    Faculty of Chemistry

    5449
  • Blood Test to Identify People at High Risk for Lung Cancer (No. T4-1033)

    A novel diagnostic test to identify individuals with increased risk of lung cancer ... Read more
    Extension Service Zvi Livneh

    Zvi Livneh

    Faculty of Biochemistry

    5428

Pages

Subscribe to Pharmaceuticals